Buy CRISPR Therapeutics Stock | CRSP Stock Price & Latest News | Public
CRSP

CRISPR Therapeutics

$0.00 (0.00%)Today

    About CRSP

    CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.51
    -0.09
    -0.7
    -1.3
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.18

    Actual EPS
    Q3 2020

    Stats

    Market Cap$6,63B
    Volume19,75k
    Price-to-Earnings Ratio202.33
    Dividend Rate
    Dividend Yield
    1 Year High$97.82
    1 Year Low$32.30
    Open$94.31
    High$94.47
    Low$92.00

    Buy any stock with any amount of money.

    Download the App
    Download the app